The Latest in Hematology News

Early-stage HL patients fare well 10 years after lower-intensity regimens

May 5, 2017

Hodgkin Lymphoma

Daratumumab, elotuzumab eyed for initial treatment of myeloma

May 4, 2017

Multiple Myeloma

House barely passes ACA repeal/replace bill

May 4, 2017

Business of Medicine

Game over: VTE is a risk in obese, sedentary teens

May 4, 2017

Could refractory T-ALL be daratumumab’s next frontier?

May 4, 2017

ALL

Watchful waiting a suitable option for pediatric acute ITP

May 4, 2017

Executive order aims to reform specialized visa program

May 4, 2017

Business of Medicine

High CD86+pDC counts may predict CML relapses

May 3, 2017

CML

In sickle cell disease, osteomyelitis is a tough call

May 3, 2017

Cord blood/placental cell combo induces rapid immune recovery

May 3, 2017

Ibrutinib monotherapy data in previously treated MZL is available

May 2, 2017

Indolent Lymphoma

Pembrolizumab advances in relapsed/refractory classic Hodgkin lymphoma

May 2, 2017

Hodgkin Lymphoma

Urgent care sites cater to cancer patients, letting them check some worries at door

May 2, 2017

Business of Medicine

Longer course of idarubicin consolidation increases leukemia-free survival

April 30, 2017

AML

Maintenance lenalidomide prolongs progression-free survival in DLBCL

April 30, 2017

Aggressive Lymphomas